$AVM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMAG PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMAG PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AMAG PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 11 2011 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jan 11 2011 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Jan 11 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jan 11 2011 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP, Chief Medical ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jan 11 2011 | AVM | AMAG PHARMACEUTICA ... | Zieziula Gary J | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jan 11 2011 | AVM | AMAG PHARMACEUTICA ... | Zieziula Gary J | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Jan 11 2011 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Jan 11 2011 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Option Exercise | A | 0.00 | 16,000 | 0 | 16,000 | |
Nov 02 2010 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 15.71 | 129,163 | 2,029,151 | 3,723,909 | 3.6 M to 3.7 M (+3.59 %) |
Nov 02 2010 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 15.91 | 820,837 | 13,059,517 | 3,594,746 | 2.8 M to 3.6 M (+29.59 %) |
Nov 02 2010 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 15.65 | 50,000 | 782,500 | 2,773,909 | 2.7 M to 2.8 M (+1.84 %) |
Dec 03 2010 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | P | 13.34 | 39 | 520 | 1,951 | 1.9 K to 2 K (+2.04 %) |
Aug 23 2010 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Sell | S | 0.00 | 13,750 | 0 | 1,912 | 15.7 K to 1.9 K (-87.79 %) |
Aug 09 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Sell | S | 30.65 | 10 | 307 | 5,092 | 5.1 K to 5.1 K (-0.20 %) |
Aug 09 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Sell | S | 0.00 | 5,790 | 0 | 5,102 | 10.9 K to 5.1 K (-53.16 %) |
Aug 06 2010 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Option Exercise | C | 0.00 | 10,000 | 0 | 10,000 | |
Aug 06 2010 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Option Exercise | C | 0.00 | 1,250 | 0 | 3,750 | |
Aug 06 2010 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | C | 0.00 | 10,000 | 0 | 15,662 | 5.7 K to 15.7 K (+176.62 %) |
Aug 06 2010 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | C | 0.00 | 1,250 | 0 | 5,662 | 4.4 K to 5.7 K (+28.33 %) |
Aug 06 2010 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO and CBO | Option Exercise | C | 0.00 | 15,000 | 0 | 15,000 | |
Aug 06 2010 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO and CBO | Sell | S | 0.00 | 15,750 | 0 | 1,136 | 16.9 K to 1.1 K (-93.27 %) |
Aug 06 2010 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO and CBO | Buy | C | 0.00 | 15,000 | 0 | 16,886 | 1.9 K to 16.9 K (+795.33 %) |
Jun 09 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Option Exercise | C | 0.00 | 2,500 | 0 | 2,500 | |
Jun 09 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Sell | S | 32.45 | 100 | 3,245 | 10,892 | 11 K to 10.9 K (-0.91 %) |
Jun 09 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Sell | S | 32.46 | 295 | 9,576 | 10,992 | 11.3 K to 11 K (-2.61 %) |
Jun 09 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Sell | S | 32.47 | 400 | 12,988 | 11,287 | 11.7 K to 11.3 K (-3.42 %) |
Jun 09 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Sell | S | 32.46 | 100 | 3,246 | 11,687 | 11.8 K to 11.7 K (-0.85 %) |
Jun 09 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Sell | S | 32.46 | 300 | 9,738 | 11,787 | 12.1 K to 11.8 K (-2.48 %) |
Jun 09 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Buy | C | 0.00 | 2,500 | 0 | 12,087 | 9.6 K to 12.1 K (+26.08 %) |
Jun 01 2010 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | P | 27.06 | 626 | 16,940 | 4,412 | 3.8 K to 4.4 K (+16.53 %) |
Jun 01 2010 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO and CBO | Buy | P | 27.06 | 658 | 17,805 | 1,886 | 1.2 K to 1.9 K (+53.58 %) |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | Russell Lesley | Director | Option Exercise | A | 0.00 | 1,900 | 0 | 1,900 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | Russell Lesley | Director | Option Exercise | A | 31.32 | 3,800 | 119,016 | 3,800 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | PEREZ ROBERT J | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | PEREZ ROBERT J | Director | Option Exercise | A | 31.32 | 5,000 | 156,600 | 5,000 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | ZWANZIGER RON | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | ZWANZIGER RON | Director | Option Exercise | A | 31.32 | 5,000 | 156,600 | 5,000 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | A | 31.32 | 5,000 | 156,600 | 5,000 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | Bonventre Joseph Vincent | Director | Option Exercise | A | 0.00 | 2,500 | 0 | 2,500 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | Bonventre Joseph Vincent | Director | Option Exercise | A | 31.32 | 5,000 | 156,600 | 5,000 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
May 27 2010 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 31.32 | 10,000 | 313,200 | 10,000 | |
May 03 2010 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | C | 0.00 | 5,000 | 0 | 5,000 | |
May 03 2010 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Buy | C | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
May 03 2010 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO and CBO | Option Exercise | C | 0.00 | 750 | 0 | 750 | |
May 03 2010 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO and CBO | Buy | C | 0.00 | 750 | 0 | 1,228 | 478 to 1.2 K (+156.90 %) |
Apr 27 2010 | AVM | AMAG PHARMACEUTICA ... | Zieziula Gary J | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Apr 27 2010 | AVM | AMAG PHARMACEUTICA ... | Zieziula Gary J | EVP, Chief Commerci ... | Option Exercise | A | 37.46 | 50,000 | 1,873,000 | 50,000 | |
Feb 25 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Option Exercise | A | 0.00 | 3,333 | 0 | 3,333 | |
Feb 25 2010 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | SVP, Operations | Option Exercise | A | 38.29 | 10,000 | 382,900 | 10,000 | |
Feb 25 2010 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP, Commercial Ope ... | Option Exercise | A | 0.00 | 3,333 | 0 | 3,333 | |
Feb 25 2010 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP, Commercial Ope ... | Option Exercise | A | 38.29 | 10,000 | 382,900 | 10,000 | |
Feb 25 2010 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Option Exercise | A | 0.00 | 5,417 | 0 | 5,417 | |
Feb 25 2010 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Option Exercise | A | 38.29 | 16,250 | 622,213 | 16,250 | |
Feb 25 2010 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | CFO, CBO and Exec V ... | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
Feb 25 2010 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | CFO, CBO and Exec V ... | Option Exercise | A | 38.29 | 22,500 | 861,525 | 22,500 | |
Feb 25 2010 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | A | 0.00 | 15,833 | 0 | 15,833 | |
Feb 25 2010 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | A | 38.29 | 47,500 | 1,818,775 | 47,500 | |
Dec 17 2009 | AVM | AMAG PHARMACEUTICA ... | Russell Lesley | Director | Option Exercise | A | 38.09 | 3,333 | 126,954 | 3,333 | |
Dec 02 2009 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | CFO and Chief Busin ... | Buy | P | 31.78 | 172 | 5,466 | 478 | 306 to 478 (+56.21 %) |
Dec 02 2009 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP-Commercial Oper ... | Option Exercise | M | 0.00 | 750 | 0 | 750 | |
Dec 02 2009 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP-Commercial Oper ... | Sell | S | 37.47 | 750 | 28,103 | 0 | 750 to 0 (-100.00 %) |
Dec 02 2009 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP-Commercial Oper ... | Buy | M | 0.00 | 750 | 0 | 750 | 0 to 750 |
Dec 02 2009 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | P | 31.78 | 116 | 3,686 | 3,786 | 3.7 K to 3.8 K (+3.16 %) |
Nov 16 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 43.00 | 46,900 | 2,016,517 | 2,723,909 | 2.7 M to 2.7 M (+1.75 %) |
Nov 16 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 43.00 | 50,000 | 2,149,775 | 2,677,009 | 2.6 M to 2.7 M (+1.90 %) |
Nov 16 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 42.97 | 3,100 | 133,213 | 2,627,009 | 2.6 M to 2.6 M (+0.12 %) |
Nov 13 2009 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | EVP and Chief Medic ... | Buy | P | 25.61 | 626 | 16,032 | 3,670 | 3 K to 3.7 K (+20.57 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | CFO and Chief Busin ... | Sell | S | 43.42 | 4,459 | 193,587 | 306 | 4.8 K to 306 (-93.58 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | CFO and Chief Busin ... | Buy | P | 25.61 | 529 | 13,548 | 4,765 | 4.2 K to 4.8 K (+12.49 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | M | 10.80 | 60,000 | 648,000 | 0 | |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | M | 13.55 | 8,000 | 108,400 | 0 | |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | M | 13.45 | 15,000 | 201,750 | 0 | |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | M | 8.98 | 8,000 | 71,840 | 0 | |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | M | 9.10 | 50,744 | 461,770 | 0 | |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | M | 9.10 | 55,300 | 503,230 | 50,744 | |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Sell | S | 43.20 | 60,000 | 2,591,700 | 0 | 60 K to 0 (-100.00 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Buy | M | 10.80 | 60,000 | 648,000 | 60,000 | 0 to 60 K |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Sell | S | 43.15 | 8,000 | 345,192 | 0 | 8 K to 0 (-100.00 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Buy | M | 13.55 | 8,000 | 108,400 | 8,000 | 0 to 8 K |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Sell | S | 43.39 | 15,000 | 650,850 | 0 | 15 K to 0 (-100.00 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Buy | M | 13.45 | 15,000 | 201,750 | 15,000 | 0 to 15 K |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Sell | S | 43.35 | 8,000 | 346,776 | 0 | 8 K to 0 (-100.00 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Buy | M | 8.98 | 8,000 | 71,840 | 8,000 | 0 to 8 K |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Sell | S | 44.82 | 32,967 | 1,477,680 | 0 | 33 K to 0 (-100.00 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Sell | S | 43.48 | 50,744 | 2,206,146 | 32,967 | 83.7 K to 33 K (-60.62 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Buy | M | 9.10 | 50,744 | 461,770 | 83,711 | 33 K to 83.7 K (+153.92 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Sell | S | 44.25 | 55,300 | 2,447,246 | 32,967 | 88.3 K to 33 K (-62.65 %) |
Nov 12 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Buy | M | 9.10 | 55,300 | 503,230 | 88,267 | 33 K to 88.3 K (+167.74 %) |
Nov 10 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Option Exercise | X | 42.72 | 1 | 43 | 0 | |
Nov 10 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Option Exercise | X | 42.72 | 1 | 43 | 0 | |
Nov 10 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | X | 24.75 | 477,324 | 11,813,769 | 2,623,909 | 2.1 M to 2.6 M (+22.24 %) |
Nov 10 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | J | 42.72 | 477,324 | 20,393,620 | 2,146,585 | 1.7 M to 2.1 M (+28.59 %) |
Nov 10 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | X | 24.75 | 100,000 | 2,475,000 | 2,623,909 | 2.5 M to 2.6 M (+3.96 %) |
Nov 10 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | J | 42.72 | 100,000 | 4,272,490 | 2,523,909 | 2.6 M to 2.5 M (-3.81 %) |
Nov 10 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 43.81 | 136,000 | 5,958,541 | 2,623,909 | 2.5 M to 2.6 M (+5.47 %) |
Nov 10 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 44.61 | 100,000 | 4,460,770 | 2,487,909 | 2.4 M to 2.5 M (+4.19 %) |
Nov 05 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 42.47 | 153,088 | 6,502,168 | 2,387,909 | 2.2 M to 2.4 M (+6.85 %) |
Nov 05 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 41.60 | 92,000 | 3,826,860 | 2,234,821 | 2.1 M to 2.2 M (+4.29 %) |
Oct 08 2009 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 39.41 | 5,780 | 227,790 | 5,780 | |
Aug 06 2009 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Option Exercise | C | 0.00 | 1,250 | 0 | 2,500 | |
Aug 06 2009 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Buy | C | 0.00 | 1,250 | 0 | 3,044 | 1.8 K to 3 K (+69.68 %) |
Aug 05 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | C | 0.00 | 5,000 | 0 | 5,000 | |
Aug 05 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Sell | S | 45.01 | 100 | 4,501 | 32,976 | 33.1 K to 33 K (-0.30 %) |
Aug 05 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Sell | S | 45.00 | 4,900 | 220,500 | 33,076 | 38 K to 33.1 K (-12.90 %) |
Aug 05 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Buy | C | 0.00 | 5,000 | 0 | 37,976 | 33 K to 38 K (+15.16 %) |
Aug 03 2009 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP, Commercial Ope ... | Sell | S | 45.48 | 399 | 18,147 | 0 | 399 to 0 (-100.00 %) |
Aug 03 2009 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO and CBO | Option Exercise | C | 0.00 | 750 | 0 | 1,500 | |
Aug 03 2009 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO and CBO | Buy | C | 0.00 | 750 | 0 | 4,236 | 3.5 K to 4.2 K (+21.51 %) |
Jun 09 2009 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | Sr. Vice President, ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Jun 09 2009 | AVM | AMAG PHARMACEUTICA ... | Zayas Ricardo | Sr. Vice President, ... | Option Exercise | A | 53.10 | 50,000 | 2,655,000 | 50,000 | |
Mar 16 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 25.32 | 11,028 | 279,220 | 2,142,821 | 2.1 M to 2.1 M (+0.52 %) |
Mar 11 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 25.58 | 24,751 | 633,096 | 2,131,793 | 2.1 M to 2.1 M (+1.17 %) |
Mar 11 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 25.34 | 59,858 | 1,516,880 | 2,107,042 | 2 M to 2.1 M (+2.92 %) |
Mar 06 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Option Exercise | J | 24.75 | 1 | 25 | 1 | |
Mar 06 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Option Exercise | X | 24.75 | 1 | 25 | 0 | |
Mar 06 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Option Exercise | J | 24.75 | 1 | 25 | 1 | |
Mar 06 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Option Exercise | X | 24.75 | 1 | 25 | 0 | |
Mar 06 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | X | 45.21 | 477,324 | 21,579,770 | 2,047,184 | 1.6 M to 2 M (+30.41 %) |
Mar 06 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | J | 24.75 | 477,324 | 11,813,769 | 1,569,860 | 2 M to 1.6 M (-23.32 %) |
Mar 06 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | X | 34.84 | 100,000 | 3,483,900 | 2,047,184 | 1.9 M to 2 M (+5.14 %) |
Mar 06 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Sell | J | 24.75 | 100,000 | 2,475,000 | 1,947,184 | 2 M to 1.9 M (-4.88 %) |
Mar 06 2009 | AVM | AMAG PHARMACEUTICA ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 26.64 | 133,061 | 3,544,160 | 2,047,184 | 1.9 M to 2 M (+6.95 %) |
Feb 26 2009 | AVM | AMAG PHARMACEUTICA ... | PEREZ ROBERT J | Director | Option Exercise | A | 34.26 | 10,000 | 342,600 | 10,000 | |
Feb 26 2009 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | SVP and Chief Medic ... | Option Exercise | A | 34.26 | 30,000 | 1,027,800 | 30,000 | |
Feb 26 2009 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP, Commercial Ope ... | Option Exercise | A | 34.26 | 25,000 | 856,500 | 25,000 | |
Feb 26 2009 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | A | 34.26 | 270,000 | 9,250,200 | 270,000 | |
Feb 26 2009 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO and CBO | Option Exercise | A | 34.26 | 45,000 | 1,541,700 | 45,000 | |
Jan 05 2009 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | SVP and Chief Medic ... | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
Jan 05 2009 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | SVP and Chief Medic ... | Buy | M | 0.00 | 1,250 | 0 | 1,794 | 544 to 1.8 K (+229.78 %) |
Dec 22 2008 | AVM | AMAG PHARMACEUTICA ... | LOBERG MICHAEL D | Director | Option Exercise | A | 32.27 | 5,000 | 161,350 | 5,000 | |
Dec 22 2008 | AVM | AMAG PHARMACEUTICA ... | Bonventre Joseph Vincent | Director | Option Exercise | A | 32.27 | 5,000 | 161,350 | 5,000 | |
Dec 22 2008 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 32.27 | 5,000 | 161,350 | 5,000 | |
Dec 22 2008 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | A | 32.27 | 5,000 | 161,350 | 5,000 | |
Dec 22 2008 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Option Exercise | A | 32.27 | 10,000 | 322,700 | 10,000 | |
Dec 22 2008 | AVM | AMAG PHARMACEUTICA ... | ZWANZIGER RON | Director | Option Exercise | A | 32.27 | 5,000 | 161,350 | 5,000 | |
Dec 02 2008 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Grant | A | 28.63 | 544 | 15,575 | 544 | 0 to 544 |
Dec 02 2008 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP - Commercial Op ... | Option Exercise | M | 0.00 | 750 | 0 | 1,500 | |
Dec 02 2008 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP - Commercial Op ... | Sell | S | 32.86 | 270 | 8,872 | 399 | 669 to 399 (-40.36 %) |
Dec 02 2008 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP - Commercial Op ... | Sell | S | 32.86 | 750 | 24,645 | 669 | 1.4 K to 669 (-52.85 %) |
Dec 02 2008 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP - Commercial Op ... | Buy | M | 0.00 | 750 | 0 | 1,419 | 669 to 1.4 K (+112.11 %) |
Aug 07 2008 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | EVP, CFO, and CBO | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Aug 07 2008 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | SVP of Scientific O ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Aug 07 2008 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP-Commercial Oper ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Aug 07 2008 | AVM | AMAG PHARMACEUTICA ... | ALLEN LEE F MD PhD | CMO & SVP Clinical ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
Aug 07 2008 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President & C.E.O. | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Aug 07 2008 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 41.57 | 2,000 | 83,140 | 2,000 | |
Aug 01 2008 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | SVP of Scientific O ... | Sell | S | 40.00 | 997 | 39,880 | 45 | 1 K to 45 (-95.68 %) |
Jun 13 2008 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | CFO, CBO, and Exec. ... | Buy | P | 37.50 | 1,000 | 37,500 | 3,486 | 2.5 K to 3.5 K (+40.23 %) |